BioScrip Provides Update on Annual Form 10-K Filing Status

DENVER--(BUSINESS WIRE)--BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that it will be filing a Form 12b-25 with the U.S. Securities and Exchange Commission to automatically extend the date for filing its Annual Report on Form 10-K for the year ended December 31, 2017 by 15 days in order to finalize the accounting review announced in its earnings release dated March 8, 2018. As previously disclosed, the Company, as part of its accounting review prior to filing the Form 10-K, identified a series of transactions incorrectly accounted for predominately related to certain balance sheet suspense and clearing accounts. These errors appear clerical in nature. The Company plans to disclose a material weakness related to this matter. The accounting review is nearing completion and the Company expects to be able to file timely its upcoming Form 10-K.